F(ab')2 antibody fragments against Trypanosoma cruzi calreticulin inhibit its interaction with the first component of human complement
Trypanosoma cruzi calreticulin (TcCRT), described in our laboratory, retains several important functional features from its vertebrate homologues. We have shown that recombinant TcCRT inhibits the human complement system when it binds to the collagenous portion of C1q. The generation of classical pa...
Main Authors: | LORENA AGUILAR, GALIA RAMÍREZ, CAROLINA VALCK, MARÍA C MOLINA, ÁLVARO ROJAS, WILHELM SCHWAEBLE, VIVIANA FERREIRA, ARTURO FERREIRA |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2005-01-01
|
Series: | Biological Research |
Subjects: | |
Online Access: | http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0716-97602005000200008 |
Similar Items
-
Trypanosoma cruzi Evades the Complement System as an Efficient Strategy to Survive in the Mammalian Host: The Specific Roles of Host/Parasite Molecules and Trypanosoma cruzi Calreticulin
by: Galia Ramírez-Toloza, et al.
Published: (2017-09-01) -
Is it all that bad when living with an intracellular protozoan? The role of Trypanosoma cruzi calreticulin in angiogenesis and tumor growth
by: GALIA eRAMIREZ-TOLOZA, et al.
Published: (2015-01-01) -
Comparative in vivo antiangiogenic effects of calreticulin from Trypanosoma cruzi and Homo sapiens sapiens
by: Victor Toledo, et al.
Published: (2010-01-01) -
Is the anti-tumor property of Trypanosoma cruzi infection mediated by its Calreticulin?
by: Galia Andrea Ramírez-Toloza, et al.
Published: (2016-07-01) -
Is It Possible to Intervene in the Capacity of Trypanosoma cruzi to Elicit and Evade the Complement System?
by: Galia Ramírez-Toloza, et al.
Published: (2021-12-01)